← All Biolargo, INC filings

Biolargo, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

OQX
BLGO
Biolargo, INC
DEF 14A: BioLargo Seeks Stockholder Approval for Reverse Stock Split to Pursue Nasdaq Listing
BioLargo is asking stockholders to approve a reverse stock split to meet the minimum bid price requirement for listing on the Nasdaq Capital Market.
OQX
BLGO
Biolargo, INC
DEF 14A: BioLargo Seeks Stockholder Approval for Director Elections, Executive Pay, Auditor Ratification, and New Equity Incentive Plan at 2024 Annual Meeting
BioLargo is holding its 2024 Annual Meeting of Stockholders on June 13, 2024, to vote on key proposals including the election of directors, executive compensation, auditor ratification, and the adoption of a new equity incentive plan.